Drug Delivery System

In this Healio Video Perspective, David Almeida, MD, MBA, PhD, speaks about real-world study results of the fluocinolone acetonide intravitreal implant, a long-acting drug delivery system for diabetic macular edema.

A Bay Area biotech company announced the FDA has lifted the partial clinical hold on EryDel SpA’s investigational new drug application for EryDex to treat ataxia-telangiectasia, a rare pediatric neurological disorder.

SpyGlass Pharma secured $90 million in Series C financing to conduct multiple U.S. clinical trials of its drug delivery platform, according to a press release.

Celanese has entered into an agreement with Glaukos to supply the VitalDose drug delivery platform for Glaukos’ iDose TR, according to a press release.

In this episode, I chat with Nancy Lurker, CEO and board director, about EyePoint Pharmaceuticals and their latest treatments and trials.

Specialists should take the time to learn how to perform suprachoroidal injections of triamcinolone acetonide to treat macular edema due to noninfectious uveitis.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Malik Y. Kahook, MD, discusses study data investigating the Spyglass drug delivery platform, which offers sustained delivery of bimatoprost.

In this Healio Video Perspective from Glaucoma 360 New Horizons Forum, Courtney Bovee, MD, discusses developments in the glaucoma field, including innovative surgical techniques and sustained-release drug delivery.

Biomind Labs Inc. announced it has received a Controlled Substances License and will begin an 8-month project to produce and evaluate novel hydrogel-forming microneedle arrays for transdermal delivery of therapeutic psychedelic compounds.

Nancy M. Holekamp, MD, director of retina services at Pepose Vision Institute in St. Louis, discussed results from the ARCHWAY phase 3 trial of the Port Delivery System with ranibizumab presented at the ASRS annual meeting.